FDA Import Refusal 799-8280400-5/11/1 — Aurobindo Pharma USA Inc

Aurobindo Pharma USA Inc — FEI 3008460374

The FDA refused shipment 799-8280400-5/11/1 from Aurobindo Pharma USA Inc (United States) on August 26, 2020. The refused product falls under Drugs and Biologics — ROSUVASTATIN CALCIUM. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
August 26, 2020
Country
United States
Product Category
Drugs and Biologics
Product Code
61JCL16 ROSUVASTATIN CALCIUM
Charges
75